5 Oct 2021
Find out more about CCS's senior researchers' expertise
New study to look at TMS treatment for OCD
The benefits of Transcranial Magnetic Stimulation (TMS) on people with obsessive-compulsive disorder (OCD) is the focus of a collaborative study between Monash University and the Epworth Centre for Innovation in Mental Health (ECIMH).- See full story
- For more information on the trial or to register as a participant please click here.
Highly successful Multiple Myeloma public webinar
| Mr Henry Blatman shared his lived experience of MM |
See more about the CARE program at https://www.monash.edu/medicine/ccs/blood-disease/community-engagement/upcoming-events
4 Oct 2021
15-27 Sep 2021 Central Clinical School recent publications
| Visible role models are important in the pursuit of gender equity in surgery, study finds. Image: Associate Professor Heather Cleland, Director of the Victorian Adult Burns Service, at the Alfred's annual surgical research prize presentation in 2018. |
28 Sept 2021
Mental health of front line health care workers raises red flags for current crisis in Australian hospital system
The largest, multi-professional study in the world investigating moral distress and mental health outcomes in frontline health care workers in primary and secondary care during last year’s second wave of the COVID-19 pandemic raises some serious concerns for the short and long term mental health impact for the current crisis experienced by health care workers in NSW, Victoria and the ACT.
See more about the study led by Associate Professor Natasha Smallwood.
21 Sept 2021
Gut microbe signatures may indicate adverse reaction to cancer treatments
A collaborative study involving Monash University has revealed specific gut microbiota signatures that may signal adverse body responses to cancer immunotherapy treatments.
Researchers studied a group of patients who were being treated for advanced melanoma with immune checkpoint blockade (ICB) - the main immunotherapy drugs currently used to treat cancer - to identify biomarkers of response and toxicity.
The study’s first author, Dr Miles Andrews from the Monash Central Clinical School, said that higher levels of the bacterium Bacteroides intestinalis in the gut were associated with a greater likelihood of developing moderate to severe treatment-related side effects.
16 Sept 2021
This Diversity & Inclusion Week, we want to find out how we can help you
| Please complete the CCS GEDI diversity survey |
by Drs Lenka Vodstrcil, Catherine Carmichael and Loretta Piccenna
The Central Clinical School’s Gender Equity Diversity and Inclusion (GEDI) committee aims to support and advocate for all its staff and students and regularly provides guidance or recommendations to the CCS Executive.
This Diversity & Inclusion week we would like to learn more about you and your needs. See more below or take the survey now.

